الصفحة الرئيسية مقالات إخبارية Phase 3 trial of Novavax investigational COVID-19 vaccine opens Phase 3 trial of Novavax investigational COVID-19 vaccine opens 28/12/2020 NIH- and BARDA-funded trial will enroll up to 30,000 volunteers. Read More
